Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 28% ± 8% | |
brain | 12 studies | 31% ± 15% | |
lung | 10 studies | 28% ± 10% | |
eye | 8 studies | 25% ± 10% | |
intestine | 7 studies | 26% ± 12% | |
kidney | 6 studies | 26% ± 9% | |
lymph node | 5 studies | 28% ± 5% | |
bone marrow | 4 studies | 21% ± 3% | |
uterus | 3 studies | 29% ± 13% | |
adipose | 3 studies | 20% ± 3% | |
liver | 3 studies | 41% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6205.42 | 1445 / 1445 | 100% | 40.44 | 183 / 183 |
lung | 100% | 6125.02 | 578 / 578 | 100% | 40.16 | 1155 / 1155 |
ovary | 100% | 8544.26 | 180 / 180 | 100% | 48.55 | 430 / 430 |
stomach | 100% | 5790.48 | 359 / 359 | 100% | 36.04 | 286 / 286 |
brain | 100% | 5664.70 | 2639 / 2642 | 100% | 51.45 | 703 / 705 |
intestine | 100% | 6715.16 | 966 / 966 | 99% | 34.67 | 524 / 527 |
breast | 100% | 6618.48 | 459 / 459 | 99% | 56.52 | 1108 / 1118 |
pancreas | 100% | 4514.90 | 327 / 328 | 99% | 26.14 | 176 / 178 |
skin | 100% | 6629.96 | 1809 / 1809 | 98% | 41.48 | 464 / 472 |
bladder | 100% | 6706.43 | 21 / 21 | 98% | 38.09 | 495 / 504 |
thymus | 100% | 6797.75 | 653 / 653 | 98% | 37.71 | 593 / 605 |
prostate | 100% | 6522.31 | 245 / 245 | 98% | 38.35 | 490 / 502 |
uterus | 100% | 8105.44 | 170 / 170 | 97% | 44.96 | 447 / 459 |
kidney | 100% | 4706.80 | 89 / 89 | 95% | 28.94 | 859 / 901 |
adrenal gland | 100% | 7165.20 | 258 / 258 | 86% | 17.93 | 197 / 230 |
liver | 100% | 3066.29 | 226 / 226 | 81% | 15.57 | 330 / 406 |
adipose | 100% | 5675.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5661.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 7198.65 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.00 | 1 / 1 |
muscle | 100% | 4462.50 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 3724.34 | 840 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 42.22 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 43.97 | 43 / 45 |
peripheral blood | 91% | 5206.87 | 843 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 19.14 | 71 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902455 | Biological process | negative regulation of stem cell population maintenance |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_2000736 | Biological process | regulation of stem cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006260 | Biological process | DNA replication |
GO_0006338 | Biological process | chromatin remodeling |
GO_0006334 | Biological process | nucleosome assembly |
GO_0042659 | Biological process | regulation of cell fate specification |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0007420 | Biological process | brain development |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0006335 | Biological process | DNA replication-dependent chromatin assembly |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0032991 | Cellular component | protein-containing complex |
GO_0070822 | Cellular component | Sin3-type complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0035098 | Cellular component | ESC/E(Z) complex |
GO_0005829 | Cellular component | cytosol |
GO_1904949 | Cellular component | ATPase complex |
GO_0033186 | Cellular component | CAF-1 complex |
GO_0016581 | Cellular component | NuRD complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0016589 | Cellular component | NURF complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0042393 | Molecular function | histone binding |
GO_0031492 | Molecular function | nucleosomal DNA binding |
GO_0008094 | Molecular function | ATP-dependent activity, acting on DNA |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | RBBP4 |
Protein name | RB binding protein 4, chromatin remodeling factor Histone-binding protein RBBP4 (Chromatin assembly factor 1 subunit C) (CAF-1 subunit C) (Chromatin assembly factor I p48 subunit) (CAF-I 48 kDa subunit) (CAF-I p48) (Nucleosome-remodeling factor subunit RBAP48) (Retinoblastoma-binding protein 4) (RBBP-4) (Retinoblastoma-binding protein p48) |
Synonyms | RBAP48 |
Description | FUNCTION: Core histone-binding subunit that may target chromatin assembly factors, chromatin remodeling factors and histone deacetylases to their histone substrates in a manner that is regulated by nucleosomal DNA. Component of several complexes which regulate chromatin metabolism. These include the chromatin assembly factor 1 (CAF-1) complex, which is required for chromatin assembly following DNA replication and DNA repair; the core histone deacetylase (HDAC) complex, which promotes histone deacetylation and consequent transcriptional repression; the nucleosome remodeling and histone deacetylase complex (the NuRD complex), which promotes transcriptional repression by histone deacetylation and nucleosome remodeling; the PRC2 complex, which promotes repression of homeotic genes during development; and the NURF (nucleosome remodeling factor) complex. . |
Accessions | C9JPP3 H0YDK2 ENST00000527118.5 E9PNS2 ENST00000475321.5 Q09028 ENST00000458695.6 [Q09028-4] ENST00000477563.6 ENST00000373485.5 [Q09028-3] ENST00000482190.1 H0YCT5 ENST00000526193.5 ENST00000460669.5 E9PND5 ENST00000373493.10 [Q09028-1] H0YEU5 E9PIC4 ENST00000414241.7 [Q09028-2] ENST00000463378.5 ENST00000490500.5 ENST00000492348.6 H0YF10 ENST00000445722.2 E9PNS6 |